Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | +4.90% | -0.93% | +23.70% |
08/05 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
08/05 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.70% | 125M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.59% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- KPTI Stock
- News Karyopharm Therapeutics Inc.
- RBC Upgrades Karyopharm Therapeutics to Outperform From Sector Perform, Boosts Price Target to $10 From $7, Cites 'Improving Uptake' for Xpovio, 'Promising' Mylofibrosis Data